The May 2026 Recall highlights four in‑depth conversations focused on the clinical approach to monocular vision loss. The episode opens with Dr. Dan Ackerman leading a two-part series with Drs. Valérie Biousse and Nancy J. Newman on the challenges and opportunities in diagnosing CRAO and BRAO. The episode continues with a second, two‑part series in which Dr. Justin Abbatemarco speaks with Drs. Valérie Biousse and Nancy J. Newman about updates in non‑arteritic ischemic optic neuropathy.

Podcast links:

Challenges and Opportunities in Diagnosing CRAO/BRAO - Part 1

Challenges and Opportunities in Diagnosing CRAO/BRAO - Part 2

Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 1

Updates in Non-Arteritic Ischemic Optic Neuropathy - Part 2

Related article:

Eye Stroke Protocol in the Emergency Department

Disclosures can be found at Neurology.org.

Read the related Resident & Fellow Section article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Justin Abbatemarco talks with Dr. Paulus Rommer about the evolving understanding of Epstein-Barr virus (EBV) and its role in multiple sclerosis (MS), including recent research on EBV antibodies as diagnostic markers and potential therapeutic targets.

Read the related article in JAMA Neurology.

Disclosures can be found at Neurology.org.

Dr. Andy Southerland talks with Dr. Layne Dylla about the trends in head CT use in US emergency departments from 2007 to 2022, highlighting disparities, regional variations, and the potential role of AI in optimizing imaging decisions.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. Alison Christy, the recipient of the 2026 Ted Burns Humanism in Neurology Award, about her inspiring career, innovative approaches to neurology education, and how she fosters compassion and creativity in medicine.

Disclosures can be found at Neurology.org.

Dr. Greg Cooper talks with Dr. Walter J. Koroshetz about his journey from a childhood fascination with the brain to leading the NINDS and his enduring commitment to advocacy, scientific rigor, and patient care.

Read more about the 2026 AAN President's Award.

Disclosures can be found at Neurology.org.

Dr. Greg Cooper talks with Dr. Eric Reiman about emerging antibody therapies for preclinical Alzheimer disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care.

Read the related article in The Lancet Neurology.

Disclosures can be found at Neurology.org.

Join the conversation by visiting the Letters to the Editor section.